← Leaderboards
Gary R. Matyas
Henry M. Jackson Fdn For The Adv Mil/Med
$15,326,105
Attributed
$15,326,105
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.5M · FY2012–19$5M$3.8M$2.5M$1.3M$0
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$15,326,105 · 2
By mechanism
UG3$8,166,901 · 1
DP1$7,159,204 · 1
Top collaborators
No co-investigators on record.
Most similar at Henry M. Jackson Fdn For The Adv Mil/Med
Same institution · by research overlap
- Sandhya Vasan$13,271,172
- Ann E. Jerse$14,836,536
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsAdjuvantHeroin AbuseImmunogenicityNational Institute Of Drug AbuseBaseHaptensHeroinVaccinesImmunePreclinical TestingAntibodiesAffinityRodentClinical TrialsUnited States Food And Drug AdministrationSafety TestingMedicalOutcomes ResearchHeroin OverdoseProgramsSpecificityNonhuman PrimateFormulation
Grant awards (9)
A Phase I/IIa Clinical Trial Testing the Safety and Immunogenicity of a Heroin Vaccine and its Efficacy Against Morphine Challenge.$3,797,321
UG3 · FY2019 · DA · contact PI
INTERACT Meeting with FDA on Cohort Design and Development of ALFQ as an Adjuvant for Heroin Vaccine$403,002
UG3 · FY2019 · DA · contact PI
A Phase I/IIa Clinical Trial Testing the Safety and Immunogenicity of a Heroin Vaccine and its Efficacy Against Morphine Challenge.$276,354
UG3 · FY2019 · DA · contact PI
A Phase I/IIa Clinical Trial Testing the Safety and Immunogenicity of a Heroin Vaccine and its Efficacy Against Morphine Challenge.$3,690,224
UG3 · FY2018 · DA · contact PI
Development of a Practical Heroin-HIV Vaccine$1,436,193
DP1 · FY2016 · DA · contact PI
Development of a Practical Heroin-HIV Vaccine$1,428,939
DP1 · FY2015 · DA · contact PI
Development of a Practical Heroin-HIV Vaccine$1,450,700
DP1 · FY2014 · DA · contact PI
Development of a Practical Heroin-HIV Vaccine$1,392,672
DP1 · FY2013 · DA · contact PI
Development of a Practical Heroin-HIV Vaccine$1,450,700
DP1 · FY2012 · DA · contact PI